Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fibrocell Science Inc (NASDAQ:FCSC)

0.78
Delayed Data
As of Jan 20
 -0.003 / -0.38%
Today’s Change
0.52
Today|||52-Week Range
3.78
+23.81%
Year-to-Date
No recent news for Fibrocell Science Inc.

Today’s Trading

Previous close0.78
Today’s open0.78
Day’s range0.72 - 0.84
Volume115,461
Average volume (3 months)192,726
Market cap$34.3M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-17.92%
Earnings growth (this year)+58.82%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+173.33%
P/E ratioNM
Price/Sales391.66
Price/Book2.41

Competitors

 Today’s
change
Today’s
% change
PRPHProPhase Labs Inc+0.01+0.50%
OGENOragenics Inc+0.04+6.54%
AXNAoxing Pharmaceutica...+0.00+0.73%
THLDThreshold Pharmaceut...-0.03-5.02%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateApril 4, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$492.0K
Annual profit (last year)-$34.5M
Net profit margin-7,002.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maslowski
Secretary, Senior Vice President &
General Counsel
Michael F. Marino
Corporate headquarters
Exton, Pennsylvania

Forecasts


Search for Jobs